Alphabet

Meta Platforms

NVIDIA

MICROSOFT

AMAZON COM

Apple

Alphabet's Q4 2025 earnings beat with $111B revenue. 2026 capex guidance signals massive AI infrastructure buildout to maintain cloud momentum.

Alphabet Beats Q4 Estimates, Unleashes Massive 2026 AI Spending Plan

Lifevantage

LifeVantage CEO Steve Fife retires as stock crashes 80% from peak. GLP-1 product faces headwinds after blockbuster launch.

LifeVantage CEO Steve Fife to Retire in April as GLP-1 Bet Sours

GOLDMAN SACHS GROUP

MORGAN STANLEY

BANK OF AMERICA CORP /DE/

UBS Group

Clear Street prices $1.05B IPO at $40-44/share, valuing the cloud-native prime broker at ~$12B. Revenue up 160% YoY as fintech disrupts Wall Street.

Clear Street Prices $1B IPO at ~$12B Valuation, Bringing Cloud-Native Prime Brokerage to Public Markets

ENERPAC TOOL GROUP

Enerpac shrinks board to 8 members as veteran directors Altavilla and Altmaier step down. Shareholders approve all proposals at 2026 meeting.

Enerpac Tool Group Shareholders Approve Leaner Board as Two Directors Exit After Combined 13 Years

BOSTON SCIENTIFIC

JOHNSON & JOHNSON

Medtronic

ABBOTT LABORATORIES

Boston Scientific plunges 16% after EP segment misses by $43M. Management defends 35% growth, says market expectations were too high. Champion trial data at ACC in March.

Boston Scientific Crashes 16% in Worst Day Since 1998 as EP Growth Fears Spook Investors

NIKE

EEOC files court action against Nike over alleged discrimination against white employees. Federal probe examines 16 DEI programs and layoff selection.

News

Today

Alphabet Beats Q4 Estimates, Unleashes Massive 2026 AI Spending Plan

LifeVantage CEO Steve Fife to Retire in April as GLP-1 Bet Sours

Clear Street Prices $1B IPO at ~$12B Valuation, Bringing Cloud-Native Prime Brokerage to Public Markets

Enerpac Tool Group Shareholders Approve Leaner Board as Two Directors Exit After Combined 13 Years

Boston Scientific Crashes 16% in Worst Day Since 1998 as EP Growth Fears Spook Investors

EEOC Takes Nike to Court Over DEI Policies in Landmark 'Reverse Discrimination' Probe